This EO fundamentally alters US biosafety governance, driven by national security fears & perceived past failures. It immediately halts risky research funding abroad, imposes domestic suspensions, and creates a tough enforcement framework for federal grants. Critically, it targets non-federal research. This move centralizes control & prioritizes risk elimination via punitive measures, potentially limiting international scientific cooperation crucial for global pandemic readiness.